Login
Toggle sidebar

Lint: perihilar-cholangiocarcinoma-staging

perihilar-cholangiocarcinoma-staging
Acronyms
warning

"Perihilar cholangiocarcinoma staging is, for prognostication, most commonly conducted using the TNM staging classification of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC). As of 2018, the staging criteria are in their 8th edition and reflected below 1. These criteria apply to hilar/perihilar cholangiocarcinomas (Klatskin tumour), while cancers of the intrahepatic and distal bile ducts are staged differently."

Line 1:120 · 'TNM' has no definition. Spell it out if it's unfamiliar to the audience.

"Perihilar cholangiocarcinoma staging is, for prognostication, most commonly conducted using the TNM staging classification of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC). As of 2018, the staging criteria are in their 8th edition and reflected below 1. These criteria apply to hilar/perihilar cholangiocarcinomas (Klatskin tumour), while cancers of the intrahepatic and distal bile ducts are staged differently."

Line 1:194 · 'AJCC' has no definition. Spell it out if it's unfamiliar to the audience.

"Perihilar cholangiocarcinoma staging is, for prognostication, most commonly conducted using the TNM staging classification of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC). As of 2018, the staging criteria are in their 8th edition and reflected below 1. These criteria apply to hilar/perihilar cholangiocarcinomas (Klatskin tumour), while cancers of the intrahepatic and distal bile ducts are staged differently."

Line 1:240 · 'UICC' has no definition. Spell it out if it's unfamiliar to the audience.

"TX: primary tumour cannot be assessed"

Line 5:9 · 'TX' has no definition. Spell it out if it's unfamiliar to the audience.

"NX: regional lymph nodes cannot be assessed"

Line 34:9 · 'NX' has no definition. Spell it out if it's unfamiliar to the audience.
Headings Case
warning

"Primary tumour (T)"

Line 2:5 · 'Primary tumour (T)' should use sentence-style capitalization.

"Regional lymph node (N)"

Line 30:5 · 'Regional lymph node (N)' should use sentence-style capitalization.

"Distant metastases (M)"

Line 42:5 · 'Distant metastases (M)' should use sentence-style capitalization.
Strong
warning

"TX: primary tumour cannot be assessed"

Line 5:1 · Generally, don't use bold in text: '<strong>TX</strong>'

"TX: primary tumour cannot be assessed"

Line 5:21 · Generally, don't use bold in text: '<strong> </strong>primary tumour cannot be assessed'

"T0: no evidence of primary tumour"

Line 7:1 · Generally, don't use bold in text: '<strong>T0</strong>'

"Tis: carcinoma in situ/high-grade dysplasia"

Line 9:1 · Generally, don't use bold in text: '<strong>Tis</strong>'

"T1: tumour confined to the bile duct, with extension up to the muscle layer or fibrous tissue"

Line 11:1 · Generally, don't use bold in text: '<strong>T1</strong>'

"T2:"

Line 13:1 · Generally, don't use bold in text: '<strong>T2</strong>'

"T2a: tumour invades beyond the wall of the bile duct to surrounding adipose tissue"

Line 15:1 · Generally, don't use bold in text: '<strong>T2a</strong>'

"T2b: tumour invades adjacent hepatic parenchyma"

Line 17:1 · Generally, don't use bold in text: '<strong>T2b</strong>'

"T3: tumour invades unilateral branches of the portal vein or hepatic artery"

Line 21:1 · Generally, don't use bold in text: '<strong>T3</strong>'

"T4:"

Line 24:1 · Generally, don't use bold in text: '<strong>T4</strong>'

"NX: regional lymph nodes cannot be assessed"

Line 34:1 · Generally, don't use bold in text: '<strong>NX</strong>'

"N0: no regional lymph node metastasis"

Line 36:1 · Generally, don't use bold in text: '<strong>N0</strong>'

"N1: 1-3 positive regional lymph nodes"

Line 38:1 · Generally, don't use bold in text: '<strong>N1</strong>'

"N2: 4 or more positive regional lymph nodes"

Line 40:1 · Generally, don't use bold in text: '<strong>N2</strong>'

"cM0: no evidence of metastases"

Line 45:1 · Generally, don't use bold in text: '<strong>cM0</strong>'

"cM1: distant metastasis"

Line 47:1 · Generally, don't use bold in text: '<strong>cM1</strong>'

"pM1: distant metastasis, microscopically confirmed"

Line 49:1 · Generally, don't use bold in text: '<strong>pM1</strong>'

"stage 0"

Line 54:1 · Generally, don't use bold in text: '<strong>stage 0</strong>'

"​Tis, N0, M0"

Line 55:1 · Generally, don't use bold in text: '<strong>​</strong>'

"stage IT1, N0, M0"

Line 58:1 · Generally, don't use bold in text: '<strong>stage I</strong>'

"stage II[T2a, T2b], N0, M0"

Line 61:1 · Generally, don't use bold in text: '<strong>stage II</strong>'

"stage IIIAT3, N0, M0"

Line 64:1 · Generally, don't use bold in text: '<strong>stage IIIA</strong>'

"stage IIIBT4, N0, M0"

Line 67:1 · Generally, don't use bold in text: '<strong>stage IIIB</strong>'

"stage IIIC[Any T], N1, M0"

Line 70:1 · Generally, don't use bold in text: '<strong>stage IIIC</strong>'

"stage IVA[Any T], N2, M0"

Line 73:1 · Generally, don't use bold in text: '<strong>stage IVA</strong>'

"stage IVB[Any T], [Any N], M1"

Line 76:1 · Generally, don't use bold in text: '<strong>stage IVB</strong>'
List Caps
warning

"Tis: carcinoma in situ/high-grade dysplasia"

Line 9:9 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"T2a: tumour invades beyond the wall of the bile duct to surrounding adipose tissue"

Line 15:9 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"T2b: tumour invades adjacent hepatic parenchyma"

Line 17:9 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.
Emphasis
warning

"Tis: carcinoma in situ/high-grade dysplasia"

Line 9:33 · Italics should be used only in exceptional circumstances: '<em>in situ</em>'
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Primary tumour (T)"

Line 2:1 · "Primary tumour (T)" is not a recognised heading for this article type.

"Regional lymph node (N)"

Line 30:1 · "Regional lymph node (N)" is not a recognised heading for this article type.

"Distant metastases (M)"

Line 42:1 · "Distant metastases (M)" is not a recognised heading for this article type.

"Stage groups"

Line 51:1 · "Stage groups" is not a recognised heading for this article type.
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0